Newsroom

In the US, use of the Mitra device is limited to research and non-diagnostic applications. In many countries outside the US, the Mitra device can be used as a sample collection device for clinical diagnostic applications, as referenced in some content.

by Neoteryx, on November 16,2021

November 2021 — The Mitra® microsampling device from US-based Neoteryx has been registered in Brazil as a Class 1 in vitro diagnostic (IVD) medical device by ANVISA, the Agência Nacional …

Read Story

by Neoteryx, on October 13,2021

Philadelphia, PA, October 2021 — The Science History Institute (the Institute) has announced Fasha Mahjoor as the recipient of the 21st annual Pittcon Heritage Award. Mahjoor is the founder and …

Read Story

by Neoteryx, on October 4,2021

ZA Approval of Mitra® Devices for Remote Specimen Collection at Home Gives Citizens Living in Rural Areas Greater Access to Critical Lab Services Los Angeles, USA & South Africa — …

Read Story

by Neoteryx, on September 23,2021

September 2021 — According to a preprint article slated for publication in the next issue of the journal Bioanalysis, the COVID-19 pandemic led to a shift in the way blood …

Read Story

by Neoteryx, on August 18,2021

Los Angeles, USA & Beijing, CHINA — The Mitra® microsampling device from US-based Neoteryx is now registered as a Class I in vitro diagnostic (IVD) medical device with the Chinese …

Read Story

The latest product releases, company news and microsampling industry updates from Neoteryx.

search our newsroom

news reporter resources:

If you don’t find the information & assets you need via the buttons below, please contact us here: press@neoteryx.com

Fact Sheet & FAQs

social media

subscribe to news